Increasing antiproliferative properties of endocannabinoids in n1e-115 neuroblastoma cells through inhibition of their metabolism

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Hamtiaux, Laurie ^a   Hansoulle, Laurie ^a   Dauguet, Nicolas ^b   Muccioli, Giulio G ^a   Gallez, Bernard ^a   Lambert, Didier M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; N OLEOYLETHANOLAMINE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; AMIDE; ANTINEOPLASTIC AGENT; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; N ACYLETHANOLAMINES; N-ACYLETHANOLAMINES; N-OLEOYLETHANOLAMINE; PALMITIC ACID DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL STRAIN N1E 115; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DESIGN; HYDROLYSIS; INCUBATION TIME; LIPID RAFT; MITOSIS INHIBITION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; DRUG EFFECT; METABOLISM; NEOPLASM; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

MURINAE;

ANIMALS; ANTINEOPLASTIC AGENTS; ARACHIDONIC ACIDS; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOCANNABINOIDS; ETHANOLAMINES; METABOLISM; MICE; NEOPLASMS; NEUROBLASTOMA; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES;

EID: 80055033752     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026823     Document Type: Article

References (57)

1. Gaoni Y, Mechoulam R, (1964) Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. Journal of the American Chemical Society 86: 1646-1647.
2. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI, (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564 10.1038/346561a0 [doi].
3. Munro S, Thomas KL, Abu-Shaar M, (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65 10.1038/365061a0 [doi].
4. Pertwee RG, Ross RA, (2002) Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 66: 101-121 10.1054/plef.2001.0341 [doi];S0952327801903412 [pii].
5. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, et al. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457 10.1038/22761 [doi].
6. Brown AJ, (2007) Novel cannabinoid receptors. Br J Pharmacol 152: 567-575 0707481 [pii];10.1038/sj.bjp.0707481 [doi].
7. O'Sullivan SE, (2007) Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 152: 576-582 0707423 [pii];10.1038/sj.bjp.0707423 [doi].
8. Muccioli GG, (2010) Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today pp. S1359-6446 (10)00083-8 [pii];10.1016/j.drudis.2010.03.007 [doi].
9. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, et al. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87 10.1038/384083a0 [doi].
10. Tsuboi K, Sun YX, Okamoto Y, Araki N, Tonai T, et al. (2005) Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J Biol Chem 280: 11082-11092 M413473200 [pii];10.1074/jbc.M413473200 [doi].
11. Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C, (1997) cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 272: 27218-27223.
12. Guzman M, (2003) Cannabinoids: potential anticancer agents. Nat Rev Cancer 3: 745-755 10.1038/nrc1188 [doi].
13. De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, et al. (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A 95: 8375-8380.
14. Mimeault M, Pommery N, Wattez N, Bailly C, Henichart JP, (2003) Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production. Prostate 56: 1-12 10.1002/pros.10190 [doi].
15. Herrera B, Carracedo A, Diez-Zaera M, Gomez del PT, Guzman M, et al. (2006) The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. Exp Cell Res 312: 2121-2131 S0014-4827(06)00106-6 [pii];10.1016/j.yexcr.2006.03.009 [doi].
16. Contassot E, Wilmotte R, Tenan M, Belkouch MC, Schnuriger V, et al. (2004) Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. J Neuropathol Exp Neurol 63: 956-963.
17. Jacobsson SO, Wallin T, Fowler CJ, (2001) Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J Pharmacol Exp Ther 299: 951-959.
18. De Petrocellis L, Davis JB, Di Marzo V, (2001) Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett 506: 253-256 S0014-5793(01)02934-9 [pii].
19. De Petrocellis L, Bisogno T, Ligresti A, Bifulco M, Melck D, et al. (2002) Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems. Fundam Clin Pharmacol 16: 297-302.
20. Bifulco M, Laezza C, Valenti M, Ligresti A, Portella G, et al. (2004) A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. FASEB J 18: 1606-1608 10.1096/fj.04-1754fje [doi];04-1754fje [pii].
21. Deyell RJ, Attiyeh EF, (2011) Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma. Cancer Genet 204: 113-121 S2210-7762(11)00051-2 [pii];10.1016/j.cancergen.2011.03.001 [doi].
22. Mundy WR, Radio NM, Freudenrich TM, (2010) Neuronal models for evaluation of proliferation in vitro using high content screening. Toxicology 270: 121-130 S0300-483X(10)00037-5 [pii];10.1016/j.tox.2010.02.004 [doi].
23. Grimbly C, Martin B, Karpinski E, Harvey S, (2009) Growth hormone production and action in N1E-115 neuroblastoma cells. J Mol Neurosci 39: 117-124 10.1007/s12031-009-9194-7 [doi].
24. Favier J, Lapointe S, Maliba R, Sirois MG, (2007) HIF2 alpha reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma. BMC Cancer 7: 139. 1471-2407-7-139 [pii];10.1186/1471-2407-7-139 [doi].
25. Bosier B, Tilleux S, Najimi M, Lambert DM, Hermans E, (2007) Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line. J Neurochem 102: 1996-2007 JNC4679 [pii];10.1111/j.1471-4159.2007.04679.x [doi].
26. Muccioli GG, Stella N, (2008) An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. Anal Biochem 373: 220-228 S0003-2697(07)00639-2 [pii];10.1016/j.ab.2007.09.030 [doi].
27. Muccioli GG, Xu C, Odah E, Cudaback E, Cisneros JA, et al. (2007) Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci 27: 2883-2889 27/11/2883 [pii];10.1523/JNEUROSCI.4830-06.2007 [doi].
28. Muccioli GG, Naslain D, Backhed F, Reigstad CS, Lambert DM, et al. (2010) The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6: 392 msb201046 [pii];10.1038/msb.2010.46 [doi].
29. Sun YX, Tsuboi K, Zhao LY, Okamoto Y, Lambert DM, et al. (2005) Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Biochim Biophys Acta pp. 211-220.
30. Demorrow S, Francis H, Gaudio E, Venter J, Franchitto A, et al. (2008) The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. Am J Physiol Gastrointest Liver Physiol 295: G1150-G1158 90455.2008 [pii];10.1152/ajpgi.90455.2008 [doi].
31. Gustafsson SB, Lindgren T, Jonsson M, Jacobsson SO, (2009) Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil. Cancer Chemother Pharmacol 63: 691-701 10.1007/s00280-008-0788-5 [doi].
32. Patsos HA, Hicks DJ, Dobson RR, Greenhough A, Woodman N, et al. (2005) The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut 54: 1741-1750 gut.2005.073403 [pii];10.1136/gut.2005.073403 [doi].
33. Hsu SS, Huang CJ, Cheng HH, Chou CT, Lee HY, et al. (2007) Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicology 231: 21-29 S0300-483X(06)00650-0 [pii];10.1016/j.tox.2006.11.005 [doi].
34. Morales A, Paris R, Villanueva A, Llacuna L, Garcia-Ruiz C, et al. (2007) Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. Oncogene 26: 905-916 1209834 [pii];10.1038/sj.onc.1209834 [doi].
35. Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, et al. (2001) Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem J 358: 249-255.
36. Endsley MP, Aggarwal N, Isbell MA, Wheelock CE, Hammock BD, et al. (2007) Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. Int J Cancer 121: 984-991 10.1002/ijc.22761 [doi].
37. Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, et al. (2004) 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Res 64: 8826-8830 64/24/8826 [pii];10.1158/0008-5472.CAN-04-3136 [doi].
38. Fowler CJ, Jonsson KO, Andersson A, Juntunen J, Jarvinen T, et al. (2003) Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. Biochem Pharmacol 66: 757-767 S0006295203003927 [pii].
39. Demorrow S, Glaser S, Francis H, Venter J, Vaculin B, et al. (2007) Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts. J Biol Chem 282: 13098-13113 M608238200 [pii];10.1074/jbc.M608238200 [doi].
40. Frampton G, Coufal M, Li H, Ramirez J, Demorrow S, (2010) Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. Exp Cell Res 316: 1465-1478 S0014-4827(10)00124-2 [pii];10.1016/j.yexcr.2010.03.017 [doi].
41. Ueda N, Yamanaka K, Yamamoto S, (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J Biol Chem 276: 35552-35557 10.1074/jbc.M106261200 [doi];M106261200 [pii].
42. Linsalata M, Notarnicola M, Tutino V, Bifulco M, Santoro A, et al. (2010) Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. Anticancer Res 30: 2583-2589 30/7/2583 [pii].
43. Laezza C, Pisanti S, Crescenzi E, Bifulco M, (2006) Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. FEBS Lett 580: 6076-6082 S0014-5793(06)01205-1 [pii];10.1016/j.febslet.2006.09.074 [doi].
44. Bifulco M, Laezza C, Portella G, Vitale M, Orlando P, et al. (2001) Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J 15: 2745-2747 10.1096/fj.01-0320fje [doi];01-0320fje [pii].
45. Patsos HA, Greenhough A, Hicks DJ, Al KM, Collard TJ, et al. (2010) The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells. Int J Oncol 37: 187-193.
46. Miyato H, Kitayama J, Yamashita H, Souma D, Asakage M, et al. (2009) Pharmacological synergism between cannabinoids and paclitaxel in gastric cancer cell lines. J Surg Res 155: 40-47 S0022-4804(08)00452-6 [pii];10.1016/j.jss.2008.06.045 [doi].
47. Sarker KP, Biswas KK, Yamakuchi M, Lee KY, Hahiguchi T, et al. (2003) ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. J Neurochem 85: 50-61 1663 [pii].
48. Szoke E, Czeh G, Szolcsanyi J, Seress L, (2002) Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion. Neuroscience 115: 805-814 S0306452202004207 [pii].
49. Wasilewski M, Wieckowski MR, Dymkowska D, Wojtczak L, (2004) Effects of N-acylethanolamines on mitochondrial energetics and permeability transition. Biochim Biophys Acta 1657: 151-163 10.1016/j.bbabio.2004.05.004 [doi];S0005272804001252 [pii].
50. Athanasiou A, Clarke AB, Turner AE, Kumaran NM, Vakilpour S, et al. (2007) Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun 364: 131-137 S0006-291X(07)02107-9 [pii];10.1016/j.bbrc.2007.09.107 [doi].
51. Catanzaro G, Rapino C, Oddi S, Maccarrone M, (2009) Anandamide increases swelling and reduces calcium sensitivity of mitochondria. Biochem Biophys Res Commun 388: 439-442 S0006-291X(09)01589-7 [pii];10.1016/j.bbrc.2009.08.037 [doi].
52. Siegmund SV, Seki E, Osawa Y, Uchinami H, Cravatt BF, et al. (2006) Fatty acid amide hydrolase determines anandamide-induced cell death in the liver. J Biol Chem 281: 10431-10438 M509706200 [pii];10.1074/jbc.M509706200 [doi].
53. Simons K, Ikonen E, (1997) Functional rafts in cell membranes. Nature 387: 569-572 10.1038/42408 [doi].
54. Ma DW, (2007) Lipid mediators in membrane rafts are important determinants of human health and disease. Appl Physiol Nutr Metab 32: 341-350 h07-036 [pii];10.1139/h07-036 [doi].
55. Patra SK, (2008) Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 1785: 182-206 S0304-419X(07)00070-4 [pii];10.1016/j.bbcan.2007.11.002 [doi].
56. Bari M, Battista N, Fezza F, Finazzi-Agro A, Maccarrone M, (2005) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells.Implications for anandamide-induced apoptosis. J Biol Chem 280: 12212-12220 M411642200 [pii];10.1074/jbc.M411642200 [doi].
57. Wu WJ, Yang Q, Cao QF, Zhang YW, Xia YJ, et al. (2010) [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. Zhonghua Gan Zang Bing Za Zhi 18: 204-208.